Altered expression of CDX2 can disrupt the mucosa in protecting the host against its luminal components in the intestine, resulting in an increased expression of inflammatory mediators leading to colonic inflammation as observed in inflammatory bowel disease (IBD) [23]. Here, CDX2 is linked to colitis.